Literature DB >> 16244388

Metal ions and oxidative protein modification in neurological disease.

Lawrence M Sayre1, Paula I Moreira, Mark A Smith, George Perry.   

Abstract

This review highlights the role of oxidative stress and imbalances in metal ion homeostasis in the neurodegenerative diseases Alzheimer's disease and Parkinson's disease and in the progressive demyelinating disease multiple sclerosis. The chemistry and biochemistry of oxidative stress-induced protein damage are first described, followed by the evidence for a pathological role of oxidative stress in these disease states. It is tempting to speculate that free radical oxygen chemistry contributes to pathogenesis in all these conditions, though it is as yet undetermined what types of oxidative changes occur early in the disease, and what types are secondary manifestations of neuronal degeneration.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16244388

Source DB:  PubMed          Journal:  Ann Ist Super Sanita        ISSN: 0021-2571            Impact factor:   1.663


  39 in total

1.  Lower levels of glutathione in the brains of secondary progressive multiple sclerosis patients measured by 1H magnetic resonance chemical shift imaging at 3 T.

Authors:  I-Y Choi; S-P Lee; D R Denney; S G Lynch
Journal:  Mult Scler       Date:  2010-10-04       Impact factor: 6.312

2.  Early post-natal iron administration induces astroglial response in the brain of adult and aged rats.

Authors:  Liana Lisboa Fernandez; Maria Noêmia Martins de Lima; Felipe Scalco; Gustavo Vedana; Clívia Miwa; Arlete Hilbig; Mônica Vianna; Nadja Schröder
Journal:  Neurotox Res       Date:  2010-12-17       Impact factor: 3.911

3.  Alpha-synuclein transmission and mitochondrial toxicity in primary human foetal enteric neurons in vitro.

Authors:  Nady Braidy; Wei-Ping Gai; Ying Hua Xu; Perminder Sachdev; Gilles J Guillemin; Xing-Mai Jiang; J William O Ballard; Martin P Horan; Zhi Ming Fang; Beng H Chong; Daniel Kam Yin Chan
Journal:  Neurotox Res       Date:  2013-09-12       Impact factor: 3.911

Review 4.  Pathogenic implications of iron accumulation in multiple sclerosis.

Authors:  Rachel Williams; Cassandra L Buchheit; Nancy E J Berman; Steven M LeVine
Journal:  J Neurochem       Date:  2011-11-11       Impact factor: 5.372

Review 5.  Genetics of iron regulation and the possible role of iron in Parkinson's disease.

Authors:  Shannon L Rhodes; Beate Ritz
Journal:  Neurobiol Dis       Date:  2008-07-11       Impact factor: 5.996

6.  Different mechanisms between copper and iron in catecholamines-mediated oxidative DNA damage and disruption of gene expression in vitro.

Authors:  Yoshihiko Nishino; Motozumi Ando; Rena Makino; Koji Ueda; Yoshinori Okamoto; Nakao Kojima
Journal:  Neurotox Res       Date:  2010-10-30       Impact factor: 3.911

7.  Dairy intake is associated with brain glutathione concentration in older adults.

Authors:  In-Young Choi; Phil Lee; Douglas R Denney; Kendra Spaeth; Olivia Nast; Lauren Ptomey; Alexandra K Roth; Jo Ann Lierman; Debra K Sullivan
Journal:  Am J Clin Nutr       Date:  2014-12-10       Impact factor: 7.045

8.  Effects of omega-3 on behavioral and biochemical parameters in rats submitted to chronic mild stress.

Authors:  Aline Haas de Mello; Aline Gassenferth; Rosiane de Bona Schraiber; Luana da Rosa Souza; Drielly Florentino; Lucinéia Gainski Danielski; Evandro da Cruz Cittadin-Soares; Jucélia Jeremias Fortunato; Fabricia Petronilho; João Quevedo; Gislaine Tezza Rezin
Journal:  Metab Brain Dis       Date:  2014-06-26       Impact factor: 3.584

Review 9.  Metal ion physiopathology in neurodegenerative disorders.

Authors:  Silvia Bolognin; Luigi Messori; Paolo Zatta
Journal:  Neuromolecular Med       Date:  2009-11-28       Impact factor: 3.843

Review 10.  Trends in the molecular pathogenesis and clinical therapeutics of common neurodegenerative disorders.

Authors:  Yahya E Choonara; Viness Pillay; Lisa C Du Toit; Girish Modi; Dinesh Naidoo; Valence M K Ndesendo; Sibongile R Sibambo
Journal:  Int J Mol Sci       Date:  2009-06-03       Impact factor: 6.208

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.